CAHC Hosted a series of briefings for Capitol Hill staff on the Inflation Reduction Act and What it Means for Prescription Drug Pricing, Coverage, and Innovation.
- When: December 6, 2022 for the House of Representatives; December 14, 2022 for the House GOP Doctors Caucus; January 12, 2023 for the Senate
- Speakers
- Julia Jenkins and Jamie Sullivan, EveryLife Foundation for Rare Diseases
- Tomas Philipson, PhD, University of Chicago Harris School of Public Policy
- Joel White, CAHC
- Key Takeaways
- Discussed the agenda for the 118th Congress
- Advocated for IRA implementation transparency and accountability
- Discussed the negative impact IRA will have on innovation and employer costs
- Suggested specific reforms to address IRA challenges
- Asked for changes at CBO to ensure better scoring and transparency around how laws impact incentives, especially on innovation issues
Download Slides